Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
We won't publish economic evaluations unless offered the clinical results as well
| The first 150 words of the full text of this article appear below. |
This week we publish an economic evaluation of
screening for abdominal aortic aneurysms.1 It is based on
a randomised trial. At the same time the Lancet is
publishing the clinical results.2 Unfortunately this is a
common pattern
for the Lancet to publish the clinical
results and us to publish the economic evaluation. We have decided that
this can't continue. We will now consider for publication economic
evaluations based on clinical trials only if the clinical results are
submitted to us as well. This is partly petulance, but we think our
policy is reasonable.
The clinical world has been sceptical about economic evaluations,
worrying that it is too easy for sponsors, particularly pharmaceutical
companies, to get the results they want. Evidence shows that many
economic evaluations have been of low quality.3 But both
of these things are also true of randomised trials: many have been of
low quality,4 and pharmaceutical companies
Read all Rapid Responses